Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-30

Clinical Trial Update: Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

View source ↗

Summary

Clinical trial update reporting results of rituximab in combination with chemotherapy for follicular lymphoma (REFLECT 1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituxan (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Follicular Lymphoma | Status: COMPLETED | Results posted: 2015-09-30